[Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects*; D006689:Hodgkin Disease / Q000188:drug therapy / Q000276:immunology*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000276:immunology*; D012075:Remission, Spontaneous; D013601:T-Lymphocytes / Q000187:drug effects*
D000970:Antineoplastic Agents
Periphere T- und B-Lymphocyten nach Beendigung einer zweijährigen Cytostaticatherapie bei Patienten mit akuter lymphoblastischer Leukose, Lymphosarkom und Lymphogranulomatose in Vollremission.